期刊文献+

野生型p53对涎腺多形性腺瘤细胞突变基因的修复 被引量:2

wt-p53 gene repair for p53 mutations of salivary pleomorphic adenoma cells
原文传递
导出
摘要 目的检测涎腺多形性腺瘤基因突变方式及野生型 p53对突变基因的修复。方法留取4例涎腺多形性腺瘤新鲜标本,进行原代细胞培养。采用野生型 p53基因转染培养细胞,通过逆转录聚合酶链反应检测转染后的基因表达。提取转染后各例细胞 DNA 及对应的肿瘤组织 DNA,分别进行 PCR 反应扩增,聚丙烯酰胺凝胶电泳及核酸序列测定分析。结果 PCR-单链构象多态性分析屁示,3例出现异常电泳带。核酸序列测定结果显示,第6外显子的第203号密码子点突变;第8外显子的第272至290号密码子之间出现碱基缺失和碱基插入。野生型 p53转染后的细胞 DNA 序列分析显示,p53第6和第8外显子的5个突变位点均恢复正常。结论涎腺多形性腺瘤发生过程中具有较高频率的 p53基因突变,突变方式多样,涉及多个密码子;外源性野生型 p53可有效地修复涎腺多形性腺瘤细胞中突变的 p53基因位点。 Objective To analyze the original mutated codon of p53 gene of salivary plcomorphic adenoma (SPA) and to evaluate the repair effects of wt-p53 on SPA cells. Methods Four cases of SPA were obtained from clinical fresh samples and SPA cells were separated and cultured, and then the cells were transduced by Ad-wt-p53. The cells and the corresponding tumor tissue DNA were extracted, PCR and single strand conformational polymorphism (SSCP) and DNA sequencing analysis were performed. Results PCR-SSCP analysis showed 3 out of 4 SPA with abnormal exon 8 and abnormal exon 6. DNA sequencing analysis showed that exon 6 point mutation was found at codon 203 ( GTG→GCG), poly-codon mutations were found in exon 8 at codon 272 (GTG→GT□) ,275 (TGT→T□T) ,276 (GCC→□CC) and at codon 290 (CGC→CGCC). After transduced by Ad-wt-p53, all of the mutated codons were repaired. Conclusions p53 gene mutation involved many codons that occurred frequently in the tumorigenesis of SPA. Exogenous wt-p53 could compensate and repair all the mutated p53 codons of SPA cells. SPA cells transduced by Ad-wt-p53 showed the typical apoptosis.
出处 《中华口腔医学杂志》 CAS CSCD 北大核心 2007年第3期144-147,共4页 Chinese Journal of Stomatology
基金 国家自然科学基金(30271422) 河北省自然科学基金(C2004000624)
关键词 涎腺 腺瘤 多形性 基因 P53 Salivary gland Adenoma,pleomorphic C.ene,p53
  • 相关文献

参考文献15

二级参考文献28

  • 1王洁,吴奇光,孙开华,贲呈瑞.多形性腺瘤的计量病理学研究[J].口腔医学纵横,1997,13(1):7-10. 被引量:4
  • 2王洁 董福生.ras p21与p53基因蛋白在涎腺多形性腺瘤中表达的定量研究[J].中华口腔医学杂志,1997,32:11-11. 被引量:1
  • 3O'Malley BW, Li D. Combination gene therapy for salivary gland cancer. Ann N Y Acad Sci 1998,842:163 - 170. 被引量:1
  • 4O'Malley BW,Cope KA,Chen SH, et al. Combination gene therapy for oral cancer in a murine model. Cancer Res 1996,56 (8): 1737 -1741. 被引量:1
  • 5Sewell DA, Li D, Duan L, et al. Optimizing suicide gene therapy for head and neck cancer. Laryngoscope 1997,107(11 Pt 1): 1490- 1495. 被引量:1
  • 6Sewell DA, Li D, Duan L, et al. Safety of in vivo adenovirusmediated thymidine kinase treatment of oral cancer. Arch Otolaryngol Head Neck Surg 1997,123(12):1298- 1302. 被引量:1
  • 7Yang L, Chiang Y, Lenz HJ, et al. Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir- based gene therapy of human gastrointestinal tumor cells. Hum Gene Therapy 1998,9(5) . 719 - 728. 被引量:1
  • 8Vincent A J, Vogels R, Someren GV, et al. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.Human Gene Therapy 1996,7(2): 197 - 205. 被引量:1
  • 9Maatta AM, Tenhunen A, Pasanen T, et al. Non-small cell lung can-cer as a target disease for herpes simplex type 1 thymidine kinase-gan-ciclovir gene therapy[J], Int J Oncol, 2004, 24(4): 943-949. 被引量:1
  • 10Hoggarth JH, Jones E, Ensser A. Functional expression of thymidine kinase in human leukaemic and colorectal cells, delivered as EGFP fu-sion protein by herpesvirus saimiri-based vector [ J ]. Cancer GeneTher, 2004,11(7): 512-518. 被引量:1

共引文献11

同被引文献20

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部